Gaviscon tab Gesves. 24 pcs mint

Description

Composition
Active substance:
Sodium alginate 250 mg, 133.5 mg of sodium hydrogen carbonate, calcium carbonate, 80 mg of
Excipients:
255 mg of mannitol, macrogol 20000 30 mg Magnesium stearate 4 mg aspartame 3.75 mg, copovidone 28 mg, 3.75 mg of acesulfame potassium, mint flavor 12 mg.
Description:
Chewable Tablets (mint) from nearly white to cream color interspersed with small, round, flat with bevelled edges, with the image of the circle and at one side of the sword and the inscription “G 250” – on the other, with mint odor.
Product form:
The packing 24 pcs.
Contraindications
• hypersensitivity to any component of the drug;
• phenylketonuria;
• Children up to age 12 years.
Precautions: In the presence of the following diseases or conditions prior to use of the drug should consult a physician: hypercalcemia and nephrocalcinosis urolithiasis with the formation of calcium-oxalate stones, congestive heart failure, renal dysfunction.
Indications
Symptomatic treatment of dyspepsia associated with gastric hyperacidity and gastroesophageal reflux (heartburn, acid regurgitation), a feeling of heaviness in the stomach after ingestion, including during pregnancy.
Interaction with other drugs
Since the calcium carbonate, part of the drug exhibits antacid activity between drug intake Geviskon® and other drugs must be at least 2 hours, particularly while receiving H2-blockers of histamine receptors, antibiotics from the group of tetracycline, digoxin, fluoroquinolone, iron salts, ketoconazole, neuroleptics, levothyroxine sodium, thyroid hormones, penicillamine, beta-blockers (atenolol, metoprolol, propranolol), corticosteroids, chloroquine, bisphosphonates and e tramustinom. Also see. Section “Special Instructions”.
Overdose
Symptoms may experience bloating.
Treatment: symptomatic.
pharmachologic effect
Pharmacological group:
Reflux esophagitis treatment for
Pharmacodynamics:
When ingestion of the drug actives Geviskon® quickly react with acidic stomach contents. Thus formed alginate gel with a pH close to neutral. The gel forms a protective barrier on the surface of the gastric contents, preventing the occurrence of gastroesophageal reflux for a period of up to four hours. In severe cases of reflux (regurgitation), the gel enters the esophagus, the stomach contents ahead of the rest, where it reduces irritation of esophageal mucosa.
Reduction of the esophageal mucosa irritation felt after 3-4 minutes after administration.
Pharmacokinetics:
The drug has no systemic bioavailability (not drawn).
Pregnancy and breast-feeding
The drug can be used during pregnancy and lactation.
Conditions of supply of pharmacies
Without recipe.
side effects
estimates of frequency of adverse reactions produced on the basis of the following criteria: very common (> 1/10), common (> 1/100, 1/1000, 1/10000,
Disorders of immune system: unknown frequency – anaphylactic and anaphylactoid reactions, hypersensitivity reactions (urticaria).
Violations of the respiratory system, thorax and mediastinum: unknown frequency – respiratory effects (bronchospasm).
If any of these instructions side effects are compounded, or you notice other effects not listed in the instructions, tell your doctor.
Storage conditions
The drug should be kept out of reach of children at a temperature not higher than 30 ° C.
Dosing and Administration
Adults and children over 12 years: inside, after careful chewing, 2-4 tablets after meals and at bedtime (up to 4 times a day).
If after 7 days of dosing symptoms persist, consult your doctor to review treatment.
Please read the instructions before taking the drug.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist